Stock Market Today, Jan. 27: UnitedHealth Group Plunges Almost 20% After Weak Earnings

Source The Motley Fool

UnitedHealth Group (NYSE:UNH), a major provider of health insurance and healtchare services, closed Tuesday at $282.69, down 19.61%. The stock sold off after Q4 results showed plunging operational earnings, hefty restructuring charges, and weaker‑than‑expected 2026 revenue guidance.

Trading volume reached 65.3 million shares, over 640% above its three-month average of 7.5 million shares. UnitedHealth Group IPO'd in 1984 and has grown 195,498% since going public.

How the markets moved today

The S&P 500 (SNPINDEX:^GSPC) added 0.41% to finish Tuesday at 6,978.60, while the Nasdaq Composite (NASDAQINDEX:^IXIC) gained 0.91% to close at 23,817.10. In managed health care, industry peers Elevance Health (NYSE:ELV) closed at $322.92, down 14.33%, and The Cigna Group (NYSE:CI) finished at $270.09, down 3.68%, as investors reacted to Medicare and earnings risks.

What this means for investors

UnitedHealth stock has been hit by a double whammy this week. Yesterday, health insurance stocks dropped on news that the government planned to limit increases to federal Medicare Advantage plans.

Today, its Q4 earnings revealed disappointing revenues and a cautious 2026 outlook. Restructuring took a big chunk out of the healthcare giant’s profits, as the company handled what it describes as “challenges on multiple fronts.”

UnitedHealth foresees revenue of $439.0 billion this year, down from $447.6 billion for 2025. Cutting back its operations, particularly its Optum services division, will reduce revenues. Medicare pressures may continue to weigh on the entire sector as investors reset expectations and wait for further clarity.

Where to invest $1,000 right now

When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor’s total average return is 946%* — a market-crushing outperformance compared to 196% for the S&P 500.

They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor.

See the stocks »

*Stock Advisor returns as of January 27, 2026.

Emma Newbery has no position in any of the stocks mentioned. The Motley Fool recommends UnitedHealth Group. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Ethereum (ETH) Price Closes Above $3,900 — Is a New All-Time High Possible Before 2024 Ends?Once again, the price of Ethereum (ETH) has risen above $3,900. This bounce has hinted at a further price increase for the altcoin before the end of the year.
Author  Beincrypto
Dec 17, 2024
Once again, the price of Ethereum (ETH) has risen above $3,900. This bounce has hinted at a further price increase for the altcoin before the end of the year.
placeholder
Gold moves away from record high as safe-haven demand fades on easing trade war concernsGold (XAU/USD) is seen extending the previous day's modest pullback from the vicinity of the $4,900 mark, or a fresh all-time peak, and drifting lower through the Asian session on Thursday.
Author  FXStreet
Jan 22, Thu
Gold (XAU/USD) is seen extending the previous day's modest pullback from the vicinity of the $4,900 mark, or a fresh all-time peak, and drifting lower through the Asian session on Thursday.
placeholder
Gold Price Forecast: XAU/USD gains momentum to near $5,050 amid geopolitical risks, Fed uncertaintyGold price (XAU/USD) extends its upside to around $5,050 during the early Asian session on Tuesday. The precious metal gains momentum amid growing concerns about financial and geopolitical uncertainty. The US ADP Employment Change and Consumer Confidence reports will be published later on Tuesday.
Author  FXStreet
23 hours ago
Gold price (XAU/USD) extends its upside to around $5,050 during the early Asian session on Tuesday. The precious metal gains momentum amid growing concerns about financial and geopolitical uncertainty. The US ADP Employment Change and Consumer Confidence reports will be published later on Tuesday.
placeholder
Santiment Says XRP and Ethereum Look “Undervalued” on 30-Day MVRVSantiment says XRP and Ethereum sit in a 30-day MVRV “undervalued” zone, with XRP at -5.7% and ETH at -7.6%, while Bitcoin is listed at 3.7% and XRP has rebounded above $1.9 after dipping to $1.8 on Sunday.
Author  Mitrade
18 hours ago
Santiment says XRP and Ethereum sit in a 30-day MVRV “undervalued” zone, with XRP at -5.7% and ETH at -7.6%, while Bitcoin is listed at 3.7% and XRP has rebounded above $1.9 after dipping to $1.8 on Sunday.
placeholder
Bitcoin’s ‘Bottoming Phase’ Ends: Five Key Things to Watch This WeekBitcoin struggles with precarious positioning amidst macroeconomic volatility, closing the week below key support and setting the stage for potential further declines.
Author  Mitrade
14 hours ago
Bitcoin struggles with precarious positioning amidst macroeconomic volatility, closing the week below key support and setting the stage for potential further declines.
goTop
quote